These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16966287)

  • 1. High efficacy of the CHOP + rituximab association in a case of primary rectal non-Hodgkin lymphoma (NHL).
    Vassallo E; Di Noto L; Palmeri L; Vaglica M; Pancera G; Palmeri S
    Leuk Lymphoma; 2006 Aug; 47(8):1686-7. PubMed ID: 16966287
    [No Abstract]   [Full Text] [Related]  

  • 2. Effective immunochemotherapy for aggressive non-Hodgkin's lymphoma.
    Coiffier B
    Semin Oncol; 2004 Feb; 31(1 Suppl 2):7-11. PubMed ID: 15042528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.
    Hainsworth JD; Spigel DR; Markus TM; Shipley D; Thompson D; Rotman R; Dannaher C; Greco FA
    Clin Lymphoma Myeloma; 2009 Jun; 9(3):223-8. PubMed ID: 19525191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: positron emission tomography images before and after therapy: a case report.
    Ustaalioglu BB; Bilici A; Seker M; Canpolat N; Ozdemir N; Salepci T; Gumus M
    Leuk Res; 2010 Apr; 34(4):e108-10. PubMed ID: 19931906
    [No Abstract]   [Full Text] [Related]  

  • 5. A meta-analysis on Rituximab combined CHOP chemotherapy for non-Hodgkin lymphoma in China.
    Hou S; Yang W
    Saudi Med J; 2011 Jul; 32(7):675-8. PubMed ID: 21748202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.
    Kaplan LD; Lee JY; Ambinder RF; Sparano JA; Cesarman E; Chadburn A; Levine AM; Scadden DT
    Blood; 2005 Sep; 106(5):1538-43. PubMed ID: 15914552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study.
    Haioun C; Salar A; Pettengell R; Johnsen HE; Duehrsen U; Rossi FG; Verhoef G; Schwenkglenks M; Jaeger U; Hamilton L; Pujol B; Lugtenburg PJ
    Leuk Lymphoma; 2011 May; 52(5):796-803. PubMed ID: 21338278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas.
    Hagemeister F; Rodriguez MA; Deitcher SR; Younes A; Fayad L; Goy A; Dang NH; Forman A; McLaughlin P; Medeiros LJ; Pro B; Romaguera J; Samaniego F; Silverman JA; Sarris A; Cabanillas F
    Br J Haematol; 2013 Sep; 162(5):631-8. PubMed ID: 23802738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial nodular lymphocyte predominant Hodgkin lymphoma: Successful treatment with CHOP plus rituximab.
    Unal A; Sari I; Deniz K; Ozkan M; Kontas O; Eser B; Cetin M
    Leuk Lymphoma; 2005 Nov; 46(11):1613-7. PubMed ID: 16236615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical investigations in aggressive non-Hodgkin lymphoma.
    Jonathan F
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
    [No Abstract]   [Full Text] [Related]  

  • 11. Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old.
    Italiano A; Jardin F; Peyrade F; Saudes L; Tilly H; Thyss A
    Haematologica; 2005 Sep; 90(9):1281-3. PubMed ID: 16154857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapsed non-Hodgkin lymphoma in fraternal twins managed successfully with rituximab maintenance therapy.
    Chakravarti A; Leslie WT; Venugopal P
    Clin Adv Hematol Oncol; 2005 Feb; 3(2):136-9; discussion 139-40. PubMed ID: 16166983
    [No Abstract]   [Full Text] [Related]  

  • 13. Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimens.
    Hohloch K; Zeynalova S; Held G; Ziepert M; Loeffler M; Wulf G; Schmitz N; Pfreundschuh M; Trümper L
    Leukemia; 2014 Nov; 28(11):2260-3. PubMed ID: 25005242
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of malignant non-Hodgkin's lymphoma. Economic impact of rituximab (Mabthera) versus conventional chemotherapy].
    Malliti M; Junot H; Fievet MH; Gabarre J; Taright N; Vernant JP; Thuillier A
    Ann Med Interne (Paris); 2003 May; 154(3):139-47. PubMed ID: 12910040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy.
    Paschal BR
    Leuk Lymphoma; 2003 Apr; 44(4):731-3. PubMed ID: 12769354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal interstitial pneumonitis related to rituximab-containing regimen.
    Herishanu Y; Polliack A; Leider-Trejo L; Grieff Y; Metser U; Naparstek E
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):407-9. PubMed ID: 16640819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma.
    Intragumtornchai T; Bunworasate U; Nakorn TN; Rojnuckarin P
    Leuk Lymphoma; 2006 Jul; 47(7):1306-14. PubMed ID: 16923561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab.
    Uchino K; Sameshima H; Miyamoto T; Iino T; Kato K; Henzan H; Aoki K; Nagafuji K; Gondo H; Harada M
    Intern Med; 2004 Feb; 43(2):131-4. PubMed ID: 15005256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of primary rectal non-Hodgkin's lymphoma treated with chemotherapy.
    Singla R; Kumar P; Bahl A; Kumar S; Saran RK; Kar P
    Trop Gastroenterol; 2008; 29(4):227-8. PubMed ID: 19323094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial.
    Gleeson M; Hawkes EA; Cunningham D; Chadwick N; Counsell N; Lawrie A; Jack A; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford J; McMillan A; Davies J; Turner D; Kruger A; Johnson PW; Gambell J; Linch D
    Br J Haematol; 2016 Nov; 175(4):668-672. PubMed ID: 27477167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.